Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppina Andreotti

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Genes|April 30, 2021
Protective Role of a <i>TMPRSS2</i> Variant on Severe COVID-19 Outcome in Young Males and Elderly WomenMaria Monticelli, Bruno Hay Mele, Elisa Benetti, et al.
Plos One|October 28, 2016
Identification of an Allosteric Binding Site on Human Lysosomal Alpha-Galactosidase Opens the Way to New Pharmacological Chaperones for Fabry DiseaseValentina Citro, Jorge Peña-García, Helena den-Haan, et al.
IUBMB Life|April 12, 2026
Lipo-Glc-1,6-P<sub>2</sub>: A Bioprecursor Prodrug for Phosphomannomutase-2 Congenital Disorder of GlycosylationFederica Sodano, Maria Monticelli, Bruno Hay Mele, et al.
International Journal of Molecular Sciences|August 12, 2022
Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG)Sandra Brasil, Mariateresa Allocca, Salvador C M Magrinho, et al.
The Biochemical Journal|January 4, 2020
Proteostasis regulators modulate proteasomal activity and gene expression to attenuate multiple phenotypes in Fabry diseaseSusanne Seemann, Mathias Ernst, Chiara Cimmaruta, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Genes|April 30, 2021
Protective Role of a <i>TMPRSS2</i> Variant on Severe COVID-19 Outcome in Young Males and Elderly WomenMaria Monticelli, Bruno Hay Mele, Elisa Benetti, et al.
Plos One|October 28, 2016
Identification of an Allosteric Binding Site on Human Lysosomal Alpha-Galactosidase Opens the Way to New Pharmacological Chaperones for Fabry DiseaseValentina Citro, Jorge Peña-García, Helena den-Haan, et al.
IUBMB Life|April 12, 2026
Lipo-Glc-1,6-P<sub>2</sub>: A Bioprecursor Prodrug for Phosphomannomutase-2 Congenital Disorder of GlycosylationFederica Sodano, Maria Monticelli, Bruno Hay Mele, et al.
International Journal of Molecular Sciences|August 12, 2022
Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG)Sandra Brasil, Mariateresa Allocca, Salvador C M Magrinho, et al.
The Biochemical Journal|January 4, 2020
Proteostasis regulators modulate proteasomal activity and gene expression to attenuate multiple phenotypes in Fabry diseaseSusanne Seemann, Mathias Ernst, Chiara Cimmaruta, et al.
Pageof 6